News for 'Sun Pharmaceuticals'

'Famotidine may become the next HCQ for Covid-19'

'Famotidine may become the next HCQ for Covid-19'

Rediff.com10 May 2020

Researchers at Northwell Health in New York are testing the effects on Famotidine (used in high intravenous doses) on Covid-19 patients as a potential treatment. After the hospital announced its clinical trials, it led to a drug shortage in the US. Back home, however, there has not been any surge in the demand for Famotidine yet.

BMC claims Mumbai received bid from Pfizer for vaccine, company denies

BMC claims Mumbai received bid from Pfizer for vaccine, company denies

Rediff.com25 May 2021

After Brihanmumbai Municipal Corporation Commissioner Iqbal Singh Chahal claimed that Mumbai has received a bid from Pfizer in response to its COVID-19 vaccine procurement tender, Pfizer issued a statement clarifying that it has made no such bid.

Remdesivir black-market thrives as Covid cases rise

Remdesivir black-market thrives as Covid cases rise

Rediff.com6 May 2021

Artificial shortages and brazen hawking of the drug on the streets at 15 times the normal price rule the day as the official machinery tries desperately to stamp out the parallel market, reports Sohini Das

FM to boost Budget spending to support economic growth

FM to boost Budget spending to support economic growth

Rediff.com31 Jan 2022

Finance Minister Nirmala Sitharaman is likely to strike a fine balance between being fiscally prudent and growth supportive when she presents her fourth straight budget on Tuesday, which is expected to have plans to boost spending to revive investment and create jobs. The Budget for the fiscal year starting April 1, 2022 is likely to raise spending on infrastructure to set the economy on a firmer footing. The stage for the Budget presentation was set by the Economic Survey stating that the government has the fiscal space to do more to support the economy that is forecast to grow at a healthy 8-8.5 per cent growth in the 2022-23 fiscal.

After 6 months in red, exports finally turn positive in Sep

After 6 months in red, exports finally turn positive in Sep

Rediff.com16 Oct 2020

After contracting for six straight months, India's exports rose 5.99 per cent to $27.58 billion in September on account of growth in shipments of drugs and pharmaceuticals and readymade garments, as per the government data released on Thursday. Exports stood at $26.02 billion in September 2019. The country's imports contracted 19.6 per cent to $30.31 billion in September.

Omicron may put export growth in slow lane

Omicron may put export growth in slow lane

Rediff.com10 Jan 2022

Uncertainty looms over India's export outlook, with the new Covid-19 variant Omicron spreading rapidly across the country's key shipment destinations. With the US and parts of Europe witnessing more than 100,000 Covid-19 cases a day, exporters expect some disruption. However, there may not be an immediate decline in exports from India because the order books remain strong at least for the next few weeks, they said.

Bharat Biotech to rectify issues with Covaxin raised by WHO

Bharat Biotech to rectify issues with Covaxin raised by WHO

Rediff.com5 Apr 2022

According to sources close to ANI, "Bharat Biotech has informed Union health ministry that it will rectify the issues pointed out by WHO in 15 to 20 days." "World Health Organisation (WHO)'s suspension is not related to safety or efficacy issues but limited only to supply for United Nations agencies."

DCGI takes BIG step for rollout of foreign vaccines in India

DCGI takes BIG step for rollout of foreign vaccines in India

Rediff.com2 Jun 2021

"It has been decided that for approval of COVID-19 vaccines in India for restricted use in emergency situation which are already approved for restricted use by US Food Drug Administration, European Medicines Agency, UK Medicines and Healthcare products Regulatory Agency, Pharmaceuticals and Medical Devices Agency Japan or which are listed in WHO Emergency Use Listing and which are well established vaccines from the stand point that millions of individuals have already been vaccinated with the said vaccines, the requirement of conducting post approval bridging clinical trials and of testing every batch of vaccine by CDL, Kasauli can be exempted, if the vaccine batch/lot has been certified and released by National Control Laboratory of country of origin," it said.

World University Rankings: Non-IITs in Top 100

World University Rankings: Non-IITs in Top 100

Rediff.com11 Apr 2022

The Saveetha Institute of Medical and Technical Sciences. The Indian School of Mines, Dhanbad. Vinay Umarji explains why these two universities have made India proud.

PM CARES Fund corpus triples to Rs 10,990 cr in FY 2020-21

PM CARES Fund corpus triples to Rs 10,990 cr in FY 2020-21

Rediff.com7 Feb 2022

The disbursal included Rs 1,000 crore for migrant welfare and over Rs 1,392 crore for procurement of Covid vaccine doses.

Brazil suspends Bharat Biotech's Covaxin clinical trials

Brazil suspends Bharat Biotech's Covaxin clinical trials

Rediff.com24 Jul 2021

The termination of the pact comes after the deal with the Brazilian government for supply of 20 million doses of the vaccine landed in controversy and attracted investigation by authorities in that country.

Budget: Concessional rate dumped, foreign dividends now under tax ambit

Budget: Concessional rate dumped, foreign dividends now under tax ambit

Rediff.com2 Feb 2022

Concessional rate of tax on dividends received by Indian companies from foreign subsidiaries will be done away with from April 1, a change that may hamper global expansion of Indian companies and compel some firms to move their headquarters out of India to geographies such as Singapore and Dubai. At present, dividends received by Indian companies from their foreign subsidiaries are subject to a concessional tax rate of 15 per cent under Section 115BBD of the Income Tax (I-T) Act. The provisions of this section shall not apply from assessment year 2023-24 onwards, according to the Finance Bill.

US trade body hails Budget, says it's fiscally prudent

US trade body hails Budget, says it's fiscally prudent

Rediff.com2 Feb 2022

In the midst of third wave of COVID-19, Finance Minister Nirmala Sitharaman has come up with an impactful Budget which is balanced, fiscally prudent and growth-oriented, the USA India Chamber of Commerce has said. President of the Boston-based USA India Chamber of Commerce (USAIC) Karun Rishi, however, said it is a matter of concern that the budget lacks tangible measures to increase revenue generation. "Opting to keep the fiscal deficit at 6.9 per cent and increase capital expenditure by 35 per cent is a masterstroke. "The annual budget estimates the effective capital expenditure of Rs 10.68 lakh crore in 2022-23, making up about 4.1 per cent of the GDP," he said. "A phenomenal increase in the government's capital expenditure is likely to facilitate the expenditures on infrastructure and create jobs.

Equity MFs Mop Up Rs 46,700 Crore

Equity MFs Mop Up Rs 46,700 Crore

Rediff.com27 Dec 2021

New fund offers collection in the current calendar year was the highest in a decade, with 13 of the 70 equity schemes cornering 75 per cent of the amount raised.

Omicron variant jab could be ready in 100 days: Pfizer

Omicron variant jab could be ready in 100 days: Pfizer

Rediff.com2 Dec 2021

Pfizer's chief executive Dr Albert Bourla told the BBC that he is of the view that annual vaccinations would be needed to maintain a "very high level of protection" against the deadly disease that has claimed over five million lives across the world.

PM to chair all-party meet on COVID on December 4

PM to chair all-party meet on COVID on December 4

Rediff.com30 Nov 2020

This will be the second all-party meeting called by the government to discuss the COVID-19 situation since the outbreak of the pandemic.

PM to meet COVID-19 vaccine manufacturers on today

PM to meet COVID-19 vaccine manufacturers on today

Rediff.com20 Apr 2021

During the meeting, scheduled to be held through video conference at 6 pm on Tuesday, the Department of Biotechnology will make a presentation and also coordinate with all the participants, sources added.

'It will take time for market to recover'

'It will take time for market to recover'

Rediff.com21 Dec 2021

'The correction could take two to three months and traders need to be careful.' 'For investors, this could be a good time to nibble in.'

What India needs to become $5 trn economy

What India needs to become $5 trn economy

Rediff.com14 Sep 2021

India will need $8 trillion (around Rs 588 lakh crore) of gross capital formation or new greenfield assets to become a $5 trillion (around Rs 368 lakh crore) economy by FY2027, a report said. The report by Deloitte said despite the COVID-19 disruption, FDI inflow into the country provides necessary optimism and display underlying strengths of the Indian economy. In FY2020-21, FDI inflows (including equity, re-invested earnings, and capital) amounted to a record $81.72 billion, 10 per cent higher than the previous financial year, it said.

Winter session begins today, farm law repeal among 26 bills on agenda

Winter session begins today, farm law repeal among 26 bills on agenda

Rediff.com29 Nov 2021

The government's agenda also includes the Cryptocurrency and Regulation of Official Digital Currency Bill, 2021.

'Rate hike will throw lot of people out from jobs'

'Rate hike will throw lot of people out from jobs'

Rediff.com23 May 2022

'Nobody is talking about the inequality that is going to come.'

August 4 was the busiest day for IPOs since 2007

August 4 was the busiest day for IPOs since 2007

Rediff.com5 Aug 2021

Retail investors-those investing up to Rs 200,000-lapped up all the four initial public offerings (IPOs) that opened for subscription on Wednesday. This is the first time since 2007 that four IPOs have been launched on a single day, according to information provided by Prime Database. KFC and Pizza Hut franchisee Devyani International (size Rs 1,838 crore); Diagnostic chains Krsnaa Diagnostics (Rs 1,213 crore), pharmaceutical firm Windlas Biotech (Rs 401 crore) and vitrified tiles manufacturer Exxaro Tiles (Rs 161 crore) are the four companies whose IPOs opened on Wednesday.

Govt gifts Rs 1.45-trillion incentive for 10 manufacturing sectors

Govt gifts Rs 1.45-trillion incentive for 10 manufacturing sectors

Rediff.com12 Nov 2020

The government hopes that the PLI schemes would provide 200,000-300,000 direct employment over five years, according to sources in the know.

Pharma majors shift focus to inhalants, nasal spray for Covid

Pharma majors shift focus to inhalants, nasal spray for Covid

Rediff.com30 Aug 2021

While Lupin is working on a Remdesivir powder for inhalation, Glenmark has tied up with a Canadian Biotech firm for nitric oxide nasal spray that reduces Sars-CoV-2 viral load and thus transmission.

'We are advising multi-cap or large-cap strategy'

'We are advising multi-cap or large-cap strategy'

Rediff.com12 Jan 2022

Neelesh Surana, who manages Mirae Asset Tax Saver and Mirae Asset Emerging Bluechip, remains constructive on Indian equities from a three to five-year time frame.

Govt lifts expenditure curbs linked to Covid-19

Govt lifts expenditure curbs linked to Covid-19

Rediff.com24 Sep 2021

The finance ministry on Friday withdrew expenditure curbs on various departments and ministries imposed in June in the wake of the COVID-19 second wave, reflecting improvement in public finances and the urgency to step up growth.

Modi: 'We need wealth creators to even distribute wealth'

Modi: 'We need wealth creators to even distribute wealth'

Rediff.com11 Feb 2021

Demoralising the private companies and disregarding their contribution won't do any good to the country or its youth as our experience has shown that private enterprises in mobile manufacturing has lead to every poor family owning a mobile phone now, while the country's private sector in the pharmaceutical space has been serving humanity through vaccines and medicines during Covid times, Modi said.

Data leak shows massive infiltration by China's Communist Party

Data leak shows massive infiltration by China's Communist Party

Rediff.com14 Dec 2020

The data leak obtained by 'The Australian' newspaper has revealed how the alleged CPC members are employed with some of the world's biggest corporations in the areas of defence, banks and pharmaceutical giants manufacturing coronavirus vaccines.

Healthcare sector likely to reach $372 bn in 2022: Niti

Healthcare sector likely to reach $372 bn in 2022: Niti

Rediff.com30 Mar 2021

Healthcare has become one of the largest sectors of the Indian economy and is expected to reach $372 billion in 2022, according to a report by Niti Aayog released on Tuesday. The report outlined a range of investment opportunities in the country's healthcare sector across hospitals, pharmaceuticals and medical devices. The report, titled 'Investment Opportunities in India's Healthcare Sector', also said India's healthcare sector has the potential to generate 27 lakh jobs in India between 2017 and 2022 -- over 5 lakh new jobs per year.

PE/VC investments decline 22% to $5.4 bn in June

PE/VC investments decline 22% to $5.4 bn in June

Rediff.com19 Jul 2021

Investments by private equity and venture capital funds declined by 22 per cent to $5.4 billion in June, as compared to the $6.9 billion in the year-ago period, a report said on Monday. However, if compared with May's $4 billion, the investments were higher by 33 per cent, the monthly report by industry lobby group IVCA and consultancy firm EY said. If one were to compare the inflows into companies in the first half of 2021, the investments were 45 per cent higher at $26.9 billion.

Taliban stop exports, imports from India

Taliban stop exports, imports from India

Rediff.com18 Aug 2021

The Taliban have stopped all imports and exports with India after entering Kabul and taking over the country on Sunday. Ajay Sahai, Director General (DG) of Federation of Indian Export Organisation (FIEO) told ANI that currently, the Taliban has stopped the movement of cargo through the transit routes of Pakistan, thereby stopping imports from the country.

PM holds meet with teams involved in developing COVID vaccine

PM holds meet with teams involved in developing COVID vaccine

Rediff.com30 Nov 2020

The teams were from Gennova Biopharmaceuticals Ltd Pune, Biological E Ltd Hyderabad and Dr Reddys Laboratories Ltd Hyderabad.

3 lakh remdesivir to be produced daily in 15 days: Govt

3 lakh remdesivir to be produced daily in 15 days: Govt

Rediff.com18 Apr 2021

The government has also given permission to 20 plants to produce the antiviral drug.

Exports jump 60% in March; falls over 7% in FY21

Exports jump 60% in March; falls over 7% in FY21

Rediff.com15 Apr 2021

The country's exports jumped by 60.29 per cent to $34.45 billion in March even as the outbound shipments contracted by 7.26 per cent during the full 2020-21 fiscal to $290.63 billion. Imports too grew by 53.74 per cent to $48.38 billion in March, but dipped by 18 per cent to $389.18 billion during April-March 2020-21, according to the government data released on Thursday. Trade deficit during March 2021 widened to $13.93 billion from $9.98 billion in March 2020.

Coronavirus may impact India's Q4 GDP growth

Coronavirus may impact India's Q4 GDP growth

Rediff.com2 Mar 2020

Sectors such as electronics, pharmaceuticals and automobiles can see supply disruptions in value chain, which may lead to a derailment of the domestic economic growth.

Expert panel grants nod to study on mixing Covaxin, Covishield

Expert panel grants nod to study on mixing Covaxin, Covishield

Rediff.com30 Jul 2021

The panel also recommended giving approval to Bharat Biotech for carrying out a study on interchangeability of its Covaxin and the under-trial adenoviral intranasal vaccine candidate BBV154, but asked the Hyderabad-based firm to remove the word "interchangeability" from the study title and submit a revised protocol for approval.

'Growth will definitely be less than 8%'

'Growth will definitely be less than 8%'

Rediff.com23 May 2022

'There will be positive growth, but if you ask me whether we are going to have the original growth rate of 8%, the answer will be, no.'

'I never thought that it's a pandemic story'

'I never thought that it's a pandemic story'

Rediff.com7 Sep 2022

'I never thought the European audience will love this film, but we had over 2,000 people at the screening.'

Mumbai still home to most of India's richest

Mumbai still home to most of India's richest

Rediff.com2 Oct 2018

Pharmaceuticals, along with software and services, also added the most new entrants on the rich list 2018.

Traders seek Army's help to distribute medicines

Traders seek Army's help to distribute medicines

Rediff.com31 Mar 2020

The situation is severe in North India as most of the logistics operation was manned by migrant labourers from Uttar Pradesh and Bihar. The problem with manpower is not only in courier and delivery services, but also at a shop level.